Vitamin D deficiency linked to higher foveal retinal thickness and decreased vascular density levels, suggests study Jacinthlyn Sylvia17 Dec 2024 8:15 PM ISTA new study published in the journal of Eye found that the amount of vitamin D and foveal retinal thickness (FRT) in children is negatively correlated...
MELT-300 Demonstrates Successful Procedural Sedation for cataract extraction in new research Dr. Kamal Kant Kohli13 Dec 2024 8:45 PM ISTMelt Pharmaceuticals a clinical-stage pharmaceutical company developing novel approaches for procedural sedation, today announced positive topline...
Elevated serum Lp(a) levels increase risk of diabetic retinopathy in T2D patients: Study Jacinthlyn Sylvia10 Dec 2024 10:00 PM ISTA new study published in the journal of International Ophthalmology found that elevated serum lipoprotein (a) [Lp(a)] concentration may double the...
Choroidal Flow Deficit Linked to Type 2 Diabetes Duration, Study Offers New Insights for DR Screening Medha Baranwal9 Dec 2024 8:45 PM ISTGermany: A recent cross-sectional study has revealed a significant link between choriocapillaris flow deficit (CC FD%) and the duration of type 2...
Fluoxetine Enhances Visual Acuity in Adults with Amblyopia Under Patching: Study Dr Riya Dave8 Dec 2024 8:15 PM ISTResearchers have found that fluoxetine improves visual acuity significantly in adults with amblyopia under standard patching therapy. A new study was...
Empagliflozin has potential of lowering progression of Diabetic Retinopathy among diabetes patients: Study Dr.Niharika Harsha B6 Dec 2024 8:45 PM ISTA recent study published in the journal JAMA Ophthalmology found that empagliflozin was associated with a reduced risk of the progression of...
Safety of Lupin's Ranibizumab (Ranieyes) established in Large-Scale Multicenter Study with 2194 injections in 1401 eyes MDTV Bureau6 Dec 2024 12:19 PM ISTReal-World Indian Data Confirms Safety of Lupin's Ranieyes for various Chorioretinal Vascular Disease Ranibizumab (Ranieyes) is a safe...
Ocular Pressure Adjusting Pump provides sustained reduction in IOP, suggests Study Dr Ishan Kataria4 Dec 2024 8:45 PM ISTGlaucoma is a leading cause of global blindness. Intraocular pressure (IOP) remains the only clinically-validated and modifiable risk factor ...
Alembic Pharma bags USFDA tentative approval for Olopatadine Hydrochloride Ophthalmic Solution to treat itchy eyes Ruchika Sharma4 Dec 2024 3:46 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Tentative Approval from the US Food & Drug Administration...
IOP Reduction during day and night benefits patients with open angle glaucoma and Normal Tension Glaucoma: Study Dr Ishan Kataria3 Dec 2024 8:30 PM ISTNocturnal intraocular pressure (IOP) profiling has shown that the peak IOP usually occurs at night, particularly in patients with glaucoma. Multiple...
USFDA nod to Gland Pharma Latanoprost Ophthalmic Solution Ruchika Sharma3 Dec 2024 2:30 PM ISTHyderabad: Gland Pharma Limited, a generic injectable-focused pharmaceutical company, has received approval from the United States Food and Drug...
Congenital cataract with persistent fetal vasculature without anterior segment pathology associated with best postoperative visual acuity: Study Dr Ishan Kataria2 Dec 2024 9:15 PM ISTCongenital cataract with persistent fetal vasculature (PFV) represents a complex and challenging condition in paediatric ophthalmology. PFV,...
